INS and type 1 diabetes mellitus: Against this background, the present meta‐analysis aimed to systematically review and analyze the safety of Ramadan fasting among patients with type 1 diabetes mellitus who were treated with either the CSII or non‐CSII (including MDI and premixed insulin) regimen.